Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 179
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

    A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics

    Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...

    A scientific approach to placenta remedies: What hormones are found in placenta tissue?

    The human placenta contains a mixture of substances which may be useful for individual postpartum treatment...

    Backer Badge Funded